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Frontotemporal dementia (FTD) is an early onset dementia associated with frontotemporal lobar degeneration 
(FTLD)1. Identiied causative loci, collectively representing ~ 40% of all FTD cases, reveal a genetic, pathological 
and mechanistic overlap with amyotrophic lateral sclerosis (ALS)2, 3. Extensive cell biological studies of these 
loci suggest RNA metabolism (TARDBP and FUS) and autophagy/endosomal-lysosomal function (CHMP2B, 
OPTN, p62, TBK1, Ubiquilin-2, VCP) as major contributors to neuronal  pathology3, 4. However, how diferent 
disease genes interact with each other in ALS/FTD pathogenesis remains poorly understood.
CHMP2B encodes a subunit of the endosomal sorting complex required for transport III (ESCRT-III) com-
plex that is recruited to the surface of early endosomes to participate in the inal step in membrane scission 
during the formation of multivesicular bodies (MVBs)5. MVBs are the endosomal and autophagosomal entry 
point to the late endosome and eventual lysosomal degradation. A splicing site mutation in CHMP2B resulting 
in a C-terminal truncation of the protein was identiied in a Danish FTD patient  cohort6 and other mis-sense 
mutations have since been identiied in FTD and ALS  pedigrees7–12. It is proposed that the truncation of the 
C-terminal in the  CHMP2BIntron5 mutant protein promotes an ‘open’ coniguration, locking the protein into 
OPEN
 ?  ǡ   ǡǡ   ? ? ? ? ?ǡǤ ?ƥ
 ǡƥǡƥ ? ?  ?ǡǤ ?Neuroscience Institute, 
  ƥǡ ƥ  ? ?  ?ǡ Ǥ ?  ǡ   ǡ   ? ?  ?ǡ
Ǥ  ? ǣ   ǡ    ǡ ǡ   ? ? ? ? ?ǡ
USA. *ǣǦǤ ?Ǥ
2Vol:.(1234567890)
SCIENTIFIC REPORTS |        (2020) 10:14221  | ǣȀȀǤȀ ? ?Ǥ ? ? ? ?Ȁ ? ? ? ? ?Ǧ ? ? ?Ǧ ? ? ? ? ?Ǧ ?
www.nature.com/scientificreports/
an association with its binding partner Snf7-2/CHMP4B13. his blockage in ESCRT-III disassembly results in 
endosomal accumulation and deicient cellular  traicking13–15.
Why neurons are particularly susceptible to mutant CHMP2B induced endosomal dysfunction is not cur-
rently understood. To address this question, we established a Drosophila model expressing  CHMP2BIntron5 post-
mitotically in the ly  eye16. Genetic screening for enhancers and suppressors of neurodegeneration in this model 
have so far identiied activated innate immune  signaling16, autophagosomal  dysfunction17, and endosomal sign-
aling  disruption18 leading to JNK/AP-1 mediated pro-apoptotic  signaling18, 19. Here, using our ly eye model 
of  CHMP2BIntron5 mediated neurodegeneration, we attempt to identify additional genetic modiiers of mutant 
CHMP2B toxicity and efectors of endosomal dysfunction. In particular, we focus on some other genes known 
to be involved in ALS/FTD pathogenesis.

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Ƥ ?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 ?Ǧ
DrosophilaǤ We previously generated a ly model of FTD-associated mutant CHMP2B neurotoxic-
ity, in which expression of  CHMP2BIntron5 but not  CHMP2BWT driven by GMR-Gal4 produced a retinal degen-
eration phenotype characterized by a few small melanin deposits in the ly  eye16. Here we irst conirmed this eye 
phenotype in lies expressing  CHMP2BIntron5 (Fig. 1a/v) but no phenotype when expressing GFP (Fig. 1a/i). To 
identify what other ALS/FTD genes may genetically interact with mutant CHMP2B, we tested mutants of ter94 
and ik2, ly homologues of VCP and TBK1, respectively, for their ability to dominantly modify the phenotype of 
ly eyes expressing  CHMP2BIntron5. We found partial loss of either ter94 (not shown) or ik2 gene were enhancers 
of mutant CHMP2B toxicity (Fig. 1a). he latter is the focus of the current study. he ik2 gene is also known as 
I-kappaB kinase ε (IKKε) in Flybase. A point mutation named Alice (ik2Alice) compromises the normal function 
of ik220. Ik2Alice heterozygous lies did not show any eye degeneration phenotype (Fig. 1a-iii). However, mutant 
CHMP2B toxicity was signiicantly enhanced in the ik2Alice heterozygous background (Fig.  1a/vi,b), suggest-
ing that ik2 is a strong genetic modiier of mutant CHMP2B toxicity in the ly eye. his inding was further 
conirmed by ik2 RNAi knockdown. he UAS-ik2 RNAi35266 line was used and validated by others  before21. 
Expression of ik2 RNAi by itself did not cause an eye phenotype (Fig. 1a/iv) but enhanced the toxicity of mutant 
CHMP2B (Fig. 1a/vii) to a much greater extent than the ik2Alice allele (Fig. 1b), presumably relecting a greater 
knockdown of Ik2 activity. To demonstrate the speciicity of the genetic interaction between ik2 and mutant 
CHMP2B, we also examined the efect of partial loss of IRD5 activity, another member of the Drosophila I kappa 
B kinase (IKK) family. he Ird5KG08072 allele did not modify the eye phenotype of mutant CHMP2B (Fig. 1a/
viii,b). hus, partial loss of Ik2 function in the presence of mutant CHMP2B may compromise the same cellular 
pathway leading to neurodegeneration.
Ik2 shares a higher identity with TBK1 (35.5%) than with other human kinases such as IKK-epsilon and 
IKK-beta (34.5% and 18.7%, respectively). Human TBK1 shares 35.5% and 18.5% identity with Ik2 and IRD5, 
respectively. hus, Ik2 appears to be the Drosophila homologue of human TBK1. Partial loss of TBK1 activ-
ity causes both ALS and  FTD22, 23. To further examine the genetic interaction between Ik2/TBK1 and mutant 
CHMP2B, we also used the Drosophila neuromuscular junction (NMJ) as the experimental system. Previously we 
reported that pan-neuronal expression of mutant CHMP2B resulted in a signiicant overgrowth at the Drosophila 
third instar larval  NMJ18, 19. Here we demonstrate that this synaptic overgrowth phenotype was also observed 
when  CHMP2BIntron5 is expressed speciically in Drosophila motor-neurons, under the control of the OK6-Gal4 
motorneuron driver. Motor-neuronal expression of  CHMP2BIntron5 resulted in a signiicant increase in bouton 
number and NMJ length coupled with a signiicant decrease in muscle surface area (Fig. 2a–d) and decline in 
overall motor function (Supplementary 2). While motor-neuronal expression of UAS-ik2 resulted in lethality, 
co-expression of Ik2 with  CHMP2BIntron5 was not lethal, presumably because the dilution of Gal4 by two UAS 
elements leading to a lower level of ectopic Ik2 expression. IK2 expression was suicient to rescue  CHMP2BIntron5 
dependent synaptic overgrowth, but co-expression of mCD8-GFP with  CHMP2BIntron5 had no efect. Normaliza-
tion of NMJ lengths and bouton numbers against muscle surface area reveals that Ik2 rescue of the  CHMP2BIntron5 
phenotypes appears to be independent of altered muscle surface area (Fig. 2e,f).
Spn-FƤ ?Ǥ Spindle F (Spn-F) is a major phos-
phorylation target of Ik2, and these two proteins form a complex that regulates several developmental processes 
in Drosophila24–26. herefore, we examined whether Spn-F is also a genetic modiier of mutant CHM2B toxicity. 
Indeed, the toxicity of mutant CHMP2B in the eye was greatly enhanced in the Spn-F2 heterozygous background 
(Fig. 3a,c); this inding was further conirmed by RNAi-mediated reduction of Spn-F activity (Fig. 3b,d), while 
lies with Spn-F RNAi knockdown did not show eye degeneration phenotypes (Supplementary 3).
Ǧ	Ǥ To determine which cellular pathways regulated by the Ik2-Spn-F complex 
are involved in mutant CHMP2B toxicity, we sought to identify other interacting proteins by immunoprecipita-
tion of Spn-F followed by mass spectrometry. We expressed UAS-EGFP-Spn-F using actin-Gal4 and used GFP 
antibody to pull down Spn-F from ly head lysates. We identiied several proteins that bind to Spn-F (Table 1). 
he most abundant was Ik2, validating the experimental approach, which also identiied Hook and dynein light 
chain 1 (Dlc1), which is encoded by the gene cut up (ctp). Although the functional homolog of Spn-F in mam-
mals is unknown, both Hook and Dlc1 are highly conserved  evolutionarily27, 28. Spn-F directly interacts with 
Dlc1 in  lies29 and Hook family proteins activate dynein adaptors in mammalian early endosome  transport30. 
hus, our interactome analysis identiied Hook as another protein that interacts with Spn-F.
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Figure 1.  Genetic interactions between CHMP2BIntron5 and ik2, the ly homologue of mammalian TBK1, a gene mutated in a subset of ALS/FTD patients. (a) Compared to control lies (i, ii), the 
majority of 1-day-old GMR-Gal4,UAS-CHMP2BIntron5/CyO lies had a weak eye degeneration phenotype (v). Partial loss of Ik2 activity through the ik2Alice allele (iii) or RNAi knockdown (iv) did 
not cause an eye phenotype but signiicantly enhanced the CHMP2BIntron5 eye phenotype (vi, vii). In contrast, partial loss of function in ird5, another ly homologue of mammalian TBK1, had no 
additional efect (viii). he eye images were taken with a Nikon DS-Fi1 camera on a Nikon SMZ1500 stereomicroscope using the NIS-Element BR sotware version 3.10. his sotware requires 
purchase and is not freely available. (b) Quantiication of eye phenotypes in lies of diferent genotypes in panel a by categorical data analysis. ***p < 0.001 by Chi-square test for three categorical 
variables (Low, Medium and High). n.s.: not signiicant.
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Figure 2.  Co-expression of Ik2 alleviates  CHMP2BIntron5-dependent overgrowth at the Drosophila larval 
neuromuscular junction (NMJ). (a) Representative micrographs of NMJs at muscle 6/7, hemi-segment A3 in 
3rd instar larvae. Scale bar: 10 μm. Leica MM AF Premier Version 1.5.0 sotware (https ://www.leica -micro syste 
ms.com/produ cts/micro scope -sotw are/) was used for imaging. Graphs were made in Graphpad prism 8 (https 
://www.graph pad.com/scien tiic -sotw are/prism /). Both sotwares are not free to use. (b,c) Increase in synaptic 
bouton number (b) and NMJ length (c) associated with expression of UAS-CHMP2BIntron5 in motor neurons 
can be ameliorated through co-expression of UAS-ik2, but not UAS-mCD8-GFP. Muscle 6/7, hemi-segment A3, 
3rd instar larvae. ANOVA with Tukey’s post-hoc multiple comparison test**p < 0.01 by ANOVA with Tukey’s 
post-hoc multiple comparison test. (d) Co-expression of UAS-ik2 has no efect on the reduced muscle sizes 
in larvae expressing UAS-CHMP2BIntron5 in motor neurons. Muscle 6/7, hemi-segment A3, 3rd instar larvae. 
****p < 0.0001 by ANOVA with Tukey’s post-hoc multiple comparison test. (e,f) Normalization of bouton 
number (e) and NMJ length (f) to account for signiicantly reduced muscle sizes. Muscle 6/7, hemi-segment A3, 
3rd instar larvae. *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001 by ANOVA with Tukey’s post-hoc multiple 
comparison test.
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HookctpƤ ?Ǥ Because Hook has a 
speciic role in early endosome  transport30, we sought to determine whether this cellular pathway contributes to 
the toxicity of mutant CHMP2B. For this analysis, we used two hook mutant alleles (hook7 and hook11) and two 
hook-speciic RNAi lines (Fig. 4a). As judged by comparison with control lies (Fig. 4a/i), Hook heterozygous 
mutant lies (Fig. 4a/ii, iii) or lies expressing hook RNAi (Fig. 4a/iv,v) appeared to have normal morphology. 
However, partial loss of Hook activity, through genetic alleles (Fig. 4a/vii,viii) or RNAi knockdown (Fig. 4a/
ix,x), greatly enhanced the retinal degeneration phenotype caused by mutant CHMP2B (Fig. 4a/vi,b). We also 
used two diferent RNAi lines to knockdown ctp expression, at least one of these RNAi lines has been previously 
characterized by  others31. We found that RNAi knockdown of ctp activity also worsened this phenotype (Fig. 5). 
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Figure 3.  Partial loss of function of Spn-F, a phosphorylation target of Ik2, enhances the toxicity of 
CHMP2BIntron5 in vivo. (a) Partial loss of Spn-F activity greatly enhanced the CHMP2BIntron5 eye phenotype, as 
judged by comparison with control lies. (b) RNAi mediated knockdown of Spn-F activity also enhanced the 
CHMP2BIntron5 eye phenotype. he eye images were taken with a Nikon DS-Fi1 camera on a Nikon SMZ1500 
stereomicroscope using the NIS-Element BR sotware version 3.10. his sotware requires purchase and is 
not freely available. (c,d) Quantiication of the eye phenotypes in panel a (c) and panel b (d) by categorical 
data analysis. ***p < 0.001 by Chi-square test for three categorical variables (Low, Medium and High). n.s.: not 
signiicant.
Table 1.  Spn-F interacting proteins identiied by mass spectrometry.
Protein name Flybase symbol Accession number Molecular weight (kDa)
Total reads
GFP-SpnF GFP
Spindle-F spn-F A0A0B4KI68 42 52 0
I-kappaB kinase ε IKKε Q7KJQ4 81 17 0
Hook Hook Q24185 77 5 0
Cut up cpt Q24117 10 4 0
Yolk protein 1 Yp1 P02843 49 3 0
Serine-arginine protein 55 B52 P26686 43 2 0
Histone H4 His4 P84040 11 3 0
Triosephosphate isomerase Tpi P29613 27 2 0
Cytochrome c oxidase subunit 4 CoI4 Q9VIQ8 21 2 0
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hus, compromised early endosome transport contributes to neurodegeneration induced by FTD3-associated 
mutant CHMP2B. 

hrough genetic interaction analysis, we irst identiied the genes encoding Ik2 and its known binding target, 
Spn-F, as strong genetic modiiers of mutant CHMP2B toxicity in Drosophila. We then identiied Hook as 
another protein that interacts with Spn-F by immunoprecipitation and mass spectrometry analyses. Exactly how 
endogenous Ik2/TBK1 and Hook family proteins interact in lies and mammalian neurons needs to be further 
investigated (Fig. 6). Further genetic studies indicated that the genes encoding Hook, an adaptor molecule for 
early endosome transport, and its binding partner Dlc1 are also strong modiiers of mutant CHMP2B toxicity. 
Together, our studies identiied three evolutionarily conserved genes, ik2, hook and ctp, as previously unknown 
genetic modiiers of FTD3-associated mutant CHMP2B and suggest that compromised early endosome transport 
contributes to neurodegeneration in FTD (Fig. 6).
CHMP2B is a subunit of ESCRT-III required for the maturation of early endosomes into  MVBs5. As expected, 
this process is disrupted by the ectopic expression of FTD3-associated mutant CHMP2B, leading to a disruption 
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a
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Figure 4.  Partial loss of function of Hook enhances the neurotoxicity of CHMP2BIntron5 in vivo. (a) As judged 
by comparison with control lies (i), multiple hook genetic alleles (ii, iii) or RNAi knockdown (iv, v) in the 
eye did not cause any eye phenotypes. In contrast, comparison with lies expressing CHMP2BIntron5 in the eye 
(vi) showed that partial loss of function of hook through genetic alleles (vii, viii) or diferent RNAi lines (ix, x) 
greatly enhanced the toxicity of CHMP2BIntron5. he eye images were taken with a Nikon DS-Fi1 camera on a 
Nikon SMZ1500 stereomicroscope using the NIS-Element BR sotware version 3.10. his sotware requires 
purchase and is not freely available. (b) Quantiication of eye phenotypes in panel a by categorical data analysis. 
**p < 0.01, ***p < 0.001, by chi-squared test for three categorical variables (Low, Medium and High).
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Figure 5.  Partial loss of function of ctp also enhances the neurotoxicity of mutant CHMP2B in vivo. (a) Eye 
morphology in lies expressing two diferent ctp-speciic RNAi lines (ii, iii) was indistinguishable from that of 
control lies (i). Comparison with lies expressing mutant CHMP2B (iv) showed that partial loss of function 
of ctp through RNAi-mediated knockdown (v, vi) enhanced mutant CHMP2B toxicity. he eye images were 
taken with a Nikon DS-Fi1 camera on a Nikon SMZ1500 stereomicroscope using the NIS-Element BR sotware 
version 3.10. his sotware requires purchase and is not freely available. (b) Quantiication of eye phenotypes in 
(a) by categorical data analysis. ***p < 0.001, **p < 0.01, by Chi-square test for three categorical variables (Low, 
Medium and High).
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Figure 6.  Schematic representation of endosome transport on microtubules mediated by the Hook-Dynein 
complex in lies (a) and mammalian cells (b). he mammalian equivalent of Spn-F remains to be identiied. 
Moreover, how endogenous Ik2/TBK1 and Hook family proteins interact in lies and mammalian neurons needs 
to be further investigated.
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of intracellular sorting or degradation of cargo proteins such as EGF  receptor13 and accumulation of aberrant 
Rab7-positive endosomal  structures13, 14. Mutant CHMP2B acts through its failure to dissociate from ESCRT-
III due to its lack of C-terminus that is required to interact with SKD1, an AAA family ATPase essential for 
ESCRT-III  dissociation13, 32. Indeed, expression of a dominant-negative form of SKD1 caused a similar endosomal 
phenotype as that induced by mutant  CHMP2B13. Moreover, mutant CHMP2B disrupts regulation of TGF-β 
and JNK signaling in the  endosome18. hus, abnormal endosomal function is a key pathological mechanism in 
FTD3. his notion is further supported by our inding here that partial loss of function in the Hook-Dlc1 com-
plex required for early endosome transport greatly exacerbates mutant CHMP2B toxicity. Taken together, these 
studies suggest that normalizing endosomal function is a promising potential therapeutic approach for FTD3.

Genetic analyses in a Drosophila model of FTD3 identify several evolutionarily conserved genes, including ik2/
TBK1, ctp/Dlc1 and hook, as genetic modiiers of mutant CHMP2B toxicity. hese indings implicate early endo-
some transport as a potential contributing pathway and, together with earlier reports, suggest that normalizing 
endosomal function is a promising potential therapeutic approach for FTD3.

	Ǥ Flies were raised at 25 °C on a standard diet. GMR-Gal4, UAS-CHMP2BIntron5 
recombined lies were generated and studied  previously16. GMR-Gal4, UAS-GFP, ik2Alice, UAS-ik2 RNAi, 
ird5KG08072, UAS-Spn-F RNAi and Ter94K15502/CyO were from the Bloomington Drosophila Stock Center. GMR-
Gal4, UAS-GFP recombined lies were generated in this study. UAS-hook RNAi (35483 and 35485), and UAS-ctp 
RNAi (43115 and 104084) were from the Vienna Drosophila RNAi Center. Spn-F2 and UAS-GFP-Spn-F ly  lines33 
were kindly provided by Dr. Hsiu-Hsiang Lee, and hook7 and hook11 ly  lines34 were from Dr. Helmut Krämer. 
he genetic aberrations of these alleles are summarized in Supplementary 1. For genetic interaction studies, the 
recombined stock, GMR-Gal4, UAS-CHMP2BIntron5/CyO, was crossed with individual classic mutants or RNAi 
lines. To quantify the CHMP2BIntron5 eye phenotype, we arbitrarily classiied the eye phenotype with or without 
enhancers into three groups based on the relative abundance of black spots on the surface of the eye.
ǡ Ǧ
ǡ   Ǥ Adult Actin-Gal4/UAS-GFP and Actin-Gal4/
UAS-GFP-Spn-F lies were frozen with dry ice and vortexed to remove the heads. Heads from each genotype 
were homogenized in lysis bufer (50 mM Tris–HCl, pH 7.5, 150-mM sodium chloride, 1% Nonidet P40, 0.5% 
sodium deoxycholate, 1 tablet of complete Mini protein inhibitor cocktail/10 mL). Homogenates were centri-
fuged at 4 °C for 20 min at 12,000g. Protein concentrations were determined with the Bradford assay (Bio-Rad). 
For co-immunoprecipitation experiments, supernatants of GFP and GFP-Spn-F with the same amount of total 
proteins were incubated with GFP magnetic beads (Chromoteck) overnight at 4 °C. he beads were incubated, 
washed three times for 15 min each with washing bufer (10 mM Tris–HCl, pH 8.0, 150 mM NaCl, 0.1% Nonidet 
P40), and then suspended in the gel loading bufer and boiled for 5 min. he co-immunoprecipitation samples 
were then run on a 10% polyacrylamide-SDS gel for a short time, and stained with a silver staining kit (Sigma) 
for subsequent digestion and downstream LC–MS/MS analysis (Proteomics and Mass Spectrometry Facility at 
UMass).
ȋȌǤ For NMJ analysis, Drosophila were raised on standard corn-
meal medium at 18 °C on a 12-h light:dark cycle. Immunohistochemistry was performed  described20. Motor-
neuronal expression was under the control of the OK6-Gal4 driver. NMJs were imaged at 40× with a Hamamatsu 
ORCA-R2 C10600-10B digital camera on a Leica DM6000B microscope itted with Qioptiq OptiGrid Struc-
tured-Light system using Leica MM AF sotware. Muscles were imaged with the same system at 10x, without the 
OptiGrid. NMJ analysis was done as  described18. Prism 7 (GraphPad Sotware) was used for statistical analysis.
ȂȀƤǤ his analysis was performed by UMass Proteomics Core Facility and 
Dr. John Leszyk provided the method description that was previously  published35, 36.
In gel digestion. Silver-stained gel bands were destained with a 1:1 ratio of potassium ferricyanide (30 mM) and 
sodium thiosulfate (100 mM). Gels were washed extensively with water to remove and destain the yellow color. 
Gel slices were cut into 1 × 1-mm pieces and placed in 1.5-ml eppendorf tubes with 1 ml of water for 30 min. 
he water was removed, and 200 µl of 250 mM ammonium bicarbonate was added. For reduction, 25 µl of a 
45-mM solution of 1,4 dithiothreitol was added, and the samples were incubated at 50 °C for 30 min. Ater cool-
ing to room temperature, the samples were alkylated by adding 25 µl of a 100-mM iodoacetamide solution for 
30 min. he gel slices were washed twice with 1-ml aliquots of water. he water was removed, and 1 ml of a 50:50 
mixture of 50-mM ammonium bicarbonate and acetonitrile was placed in each tube. Ater incubation at room 
temperature for 1 h, the solution was removed, and 200 µl of acetonitrile was added to each tube, turning the 
gel slices opaque white. he acetonitrile was removed, and the gel slices were further dried in a Speed Vac and 
rehydrated in 1,000 µl of 2 ng/µl trypsin (Sigma) in 0.01% ProteaseMAX Surfactant (Promega):50-mM ammo-
nium bicarbonate. Samples were incubated at 37 °C for 21 h. he supernatant of each sample was removed and 
placed in a separate 1.5-ml eppendorf tube. Gel slices were further dehydrated with 100 µl of an 80:20 mixture 
of acetonitrile and 1% formic acid. he extract was combined with the supernatants of each sample. he samples 
were then dried in a Speed Vac.
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LC/MS/MS on Q exactive. Ater reconstitution in 25 µl of 0.1% triluoroacetic acid in 5% acetonitrile, a 3-µl 
aliquot of each sample was directly injected onto a custom-packed 2 cm × 100 µm  C18 Magic 5-µm particle trap 
column. Peptides were eluted and sprayed from a custom-packed emitter (75 µm × 25 cm  C18 Magic 3-µm par-
ticle) with a linear gradient from 95% solvent A (0.1% formic acid in water) to 35% solvent B (0.1% formic acid 
in acetonitrile) for 90 min at a low rate of 300 nanoliters per minute on a Waters Nano Acquity UPLC system. 
Data-dependent acquisitions were done on a Q Exactive mass spectrometer (hermo Scientiic) according to an 
experiment in which full MS scans from 300 to 1,750 m/z were acquired at a resolution of 70,000 followed by 
10 MS/MS scans acquired under higher-energy collisional dissociation (HCD) fragmentation at a resolution of 
17,500 with an isolation width of 1.6 Da. Raw data iles were processed with Proteome Discoverer (hermo, ver-
sion 1.4) and then searched with Mascot Server (Matrix Sciences, version 2.5) against the human index of Uni-
prot. he search parameters used were fully tryptic with 2 missed cleavages, parent mass tolerances of 10 ppm, 
and fragment mass tolerances of 0.05 Da. Variable modiications of acetyl (protein N-term), pyro glutamic for 
N-term glutamine, oxidation of methionine, and carboxymethyl cysteine were considered.
Ǥ Signiicant diference between control and experimental groups were determined by 
using Chi-square tests to calculate P values for categorical data.
Ǥ Detailed information is also provided regarding genotypes of lies (Supplementary 4) 
and reagents (Supplementary 5) as well as values of all the statistical rest results (Supplementary 6).

he datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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